Heparin inhibits the development of intimal thickening after carotid injury in the rat; however, the specific cellular events responsible for this effect have not been defined. In this study, smooth muscle cell growth fraction and migration into the intima were quantitatively measured in heparin-treated animals. All rats were subjected to left carotid balloon injury and received continuous intraperitoneal infusion of tritiated thymidine; they were given either heparin or lactated Ringer's solution intravenously for periods of time up to 7 days. Both smooth muscle cell growth fraction and migration of nbndividing smooth muscle cells were markedly reduced in heparin-treated rats. If heparin was administered for only the first 3 days after carotid injury, both smooth muscle growth fraction and migration were reduced at 7 days; on the other hand, heparin had no effect on growth fraction and migration if given from day 4 to day 7. Finally, heparin given for a period of 1 week produced marked reduction in smooth muscle cell accumulation in injured arteries at 2 and 4 weeks. These results suggest that the effect of heparin on injury-induced intimal thickening might be due to inhibition of both smooth muscle cell entry into the growth fraction and migration of medial smooth muscle cells into the intima. These effects are long lasting, and are not reversed even if heparin is stopped after a short course of administration. (Circ Res 58: 839-845, 1986) 
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SUMMARY. Heparin inhibits the development of intimal thickening after carotid injury in the rat; however, the specific cellular events responsible for this effect have not been defined. In this study, smooth muscle cell growth fraction and migration into the intima were quantitatively measured in heparin-treated animals. All rats were subjected to left carotid balloon injury and received continuous intraperitoneal infusion of tritiated thymidine; they were given either heparin or lactated Ringer's solution intravenously for periods of time up to 7 days. Both smooth muscle cell growth fraction and migration of nbndividing smooth muscle cells were markedly reduced in heparin-treated rats. If heparin was administered for only the first 3 days after carotid injury, both smooth muscle growth fraction and migration were reduced at 7 days; on the other hand, heparin had no effect on growth fraction and migration if given from day 4 to day 7. Finally, heparin given for a period of 1 week produced marked reduction in smooth muscle cell accumulation in injured arteries at 2 and 4 weeks. These results suggest that the effect of heparin on injury-induced intimal thickening might be due to inhibition of both smooth muscle cell entry into the growth fraction and migration of medial smooth muscle cells into the intima. These effects are long lasting, and are not reversed even if heparin is stopped after a short course of administration. (Circ Res 58: 839-845, 1986) THE factors controlling smooth muscle cell (SMC) function in normal, injured, and atherosclerotic artery, although intensively sought for, remain undefined. In particular, molecules specifically regulating smooth muscle cell growth are of importance from the point of view of both vascular wall biology and clinical pharmacology, since no effective means are currently available for preventing or retarding the SMC proliferative aspect of the atherosclerotic process. Heparin and related glycosaminoglycans are potential candidates for growth regulation since: (1) they are present in the normal quiescent vessel (Radhakrishnamurthy et al., 1977; Oegema et al., 1979; Levy et al., 1981; Salisbury and Wagner, 1981; Clowes et al., 1984) ; (2) they are synthesized by both endothelial cells and SMC (Castellot et al., 1981 (Castellot et al., , 1982 Fritze et al., 1985) ; (3) they inhibit SMC migration and proliferation in vitro (Hoover et al., 1980; Castellot et al., 1981 Castellot et al., , 1982 Majack and Clowes, 1984; Orlidge and D'Amore, 1984; Fritze et al., 1985) ; (4) when administered in pharmacological amounts, they inhibit SMC proliferation and the process of intimal thickening in injured artery in vivo without affecting endothelial repair (Clowes and Karnovsky, 1977; Guyton et al., 1980; Clowes et al., 1983c; . These observations suggest that heparin may possess the requisite specificity to make it a useful pharmacological agent for the control of intimal thickening and the prevention of vascular occlusion during atherogenesis and after vascular reconstruction.
The process of intimal thickening in injured artery is the consequence of first medial SMC proliferation, smooth muscle migration from the media to the intima, and additional smooth muscle proliferation in the intima (Clowes et al., 1983a (Clowes et al., , 1983b . That SMC migration alone may be an important factor in the development of the intimal lesion was demonstrated in a previous study in which we observed that approximately 50% of the SMC migrating from the media to the intima did not subsequently divide . Furthermore, we noticed when the injured artery was exposed continuously to [ 3 H]thymidine that the measured growth fraction was between 30% and 40% of the initial population of cells, and did not change after 3 days. This observation suggested that the effect of injury was to stimulate a single cohort of cells to enter the growth cycle early, and that other quiescent cells were not stimulated to do so at later times.
In our previous investigations of the heparin effect on intimal thickening, we have observed a decrease in SMC [ 3 H]thymidine index (pulse label), a reduction in intimal thickening, and a reduction in total SMC number at late times . However, it has not been apparent whether the net reduction in intimal cell number was the consequence of decreased growth fraction, delay in cell cycle progression, increased cell death, or diminished migration of medial SMC. In this study we examine the first and last of these possibilities, and demonstrate that both entry into the growth fraction 840 and cellular migration from the media to the intima are significantly inhibited in the injured carotids of heparin-treated rats, and that these effects are of long lasting importance.
Methods
Arterial Injury Model
Male Sprague-Dawley rats weighing approximately 500 g were anesthetized with pentobarbital (12 mg/kg, ip, 60 mg/ml, Veterinary Laboratories Inc.) and Innovar (0.2 ml/kg, Innovar-Vet, Pitman-Moore, Inc ) and subjected to left common carotid balloon injury as previously described (Clowes et al., 1983a (Clowes et al., , 1983b Clowes and Schwartz, 1985) . In brief, a 2F balloon embolectomy catheter was introduced through the external branch of the carotid, advanced into the thoracic aorta, and withdrawn slowly while inflated. Repeated three times, this sequence produced complete endothelial denudation of the left common carotid. The right carotid was left untraumatized. During the same anesthesia, a 7-day 2-ml miniosmotic pump (Alza Corp.) was inserted into the subcutaneous tissue over the back and connected to an indwelling jugular venous catheter to infuse either lactated Ringer's solution (control) or heparin (Sigma, type II, 0.3 mg/kg per hr) at approximately 10 j*I/hr. Pumping was started approximately 4 hours after pump placement. Previous studies have shown that heparin administered in this fashion produces approximately 50% inhibition of SMC proliferation at 2 weeks after injury. Also, during the same anesthesia, a 2-ml 7-day miniosmotic (Alza Corp.) pump containing [ 3 H]thymidine (6.7 CI/MM, New England Nuclear) was inserted into the peritoneal cavity immediately after carotid ballooning and placement of the intravenous pump. At 1 hour and at 3 and 7 days, animals were killed and both carotids were retrieved. Two 5-mm segments were cut from the central portion of each carotid for DNA determinations (Clowes et al., 1983a) , and a third piece was removed, fixed in 2.5% glutaraldehyde in 01 M phosphate buffer, pH 7 4, and embedded in epoxy resin. Cross-sections (2 fim) were cut and autoradiograms were prepared (Clowes et al., 1983a) by dipping the slides in Kodak NTB-2 emulsion and storing them in light-tight boxes at 4°C. The autoradiograms were developed after 2 weeks, and the thymidine index (%) was determined for intimal and medial SMC separately and for entire crosssections (2 sections/animal). The "unlabeled cell index" (%) for the entire cross-section was equal to 100-thymidine index, and the unlabeled SMC DNA at any time point was equal to Vioo X (unlabeled cell index x total DNA).
The nondividing fraction, the growth fraction, and the fraction of nondividing SMC migrating for each time period (t) into the intima were calculated as follows: where unlabeled DNA, nl , ra i was equal to Vioo X (unlabeled cell index lntima X DNA, ntima ) and DNA, ntlma was equal to
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This formulation of growth fraction corrects for interanimal variation in normal carotid DNA content, and is reasonably accurate as long as the DNA of a nondividing cell and nondividing cell volume remain constant. In previous studies, we have shown that the mean DNA per cell remains constant between 0 and 12 weeks after injury (Clowes et al., 1983a) . This method of measuring growth fraction also is not influenced by the means used to mark proliferating cells, since [ 3 H]thymidine is not taken up by nondividing cells. The possibility that [ 3 H]thymidine infused chronically would alter total SMC accumulation in injured artery was eliminated in an earlier study .
The calculation of the fraction of nondividing SMC migrating from the media into the intima depends on an estimate of the intimal DNA content and direct measurement of the intimal unlabeled cell index. Since the total DNA content of the left carotid could not readily be partitioned into medial and intimal DNA, we made the approximation that DNA m ,, ma = DNAi e f, can) , l d -DNA ng ht carotid This approximation was previously validated by showing that the number of nuclei in the left carotid media per cross-section was the same as in the right carotid media .
The long-term effect of acute and limited heparin administration was assessed in two experiments. In the first, balloon-injured animals were prepared as described above with intraperitoneal [ 3 H]thymidine minipumps and subcutaneous minipumps containing either heparin (0.3 mg/ kg per hr) (group 1) or lactated Ringer's solution (group 2) for intravenous infusion. At day 3 after carotid injury, the subcutaneous pumps were switched and intravenous infusion was continued with lactated Ringer's solution (group 1) or heparin (group 2). Growth fraction and nondividing cell migration were measured at 7 days. In the second experiment, heparin (0.3 mg/kg per hr) or lactated Ringer's solution was given intravenously by means of 7-day minipumps, beginning at the time of carotid injury, and carotid DNA was measured 14 or 28 days later. Growth inhibition was calculated as described previously . The 7-day minipumps stopped pumping between day 7 and day 9, and were not removed before the animals were killed.
The specificity of the inhibition in vivo of heparin for SMC was defined in the present series of experiments by infusing heparin, chondroitin-6-sulfate, or hyaluronic acid (Sigma) intravenously at 0.3 mg/kg per hr by means of a 14-day 2-ml miniosmotic pump (Alza Corp.) placed at the time of carotid injury. Controls received lactated Ringer's solution intravenously DNA was measured as described above at 14 days, and the percent inhibition was calculated .
Partially purified (Clowes and Karnovsky, 1977; Clowes et al., 1983c; and purified heparin and fragments of heparin (Guyton et al., 1980; Hoover et al., 1980; Clowes et al., 1983c; Castellot et al., 1984) have been shown to inhibit SMC growth m vitro and in vivo. 
. Graph demonstrating changes in DNA content fog DNA/ 5-tnm vessel ± SEM) of right (uninjured) and left (injured) carotids of animals that received intravenous infusions of either lactated Ringer's solution (LR) (control) or heparin (0 3 mg/kg per hr in LR) and were killed at intervals between 0 and 7 days after surgery. All animals received continuous mtraperitoneal infusions of [ 3 H]thymtdine The differences between control and heparm-treated left carotids are significant at 3 and 7 days (P <0 05, t-test). n = 5 for each point
Results
As in previous experiments , heparin administered intravenously to rats inhibited SMC proliferation in 7-and 14-day growth assays ( Fig. 1; Table 1 ). The left carotid ballooning procedure produced an immediate decrease in DNA content which was seen by histology to be the result, not only of loss of endothelium, but, also, loss of SMC from the inner layers of the media (Clowes et al., 1983a) . The DNA content of the uninjured right carotids remained constant and was not affected by heparin administration. In a 14-day growth assay, SMC proliferation was inhibited by heparin but not chondroitin sulfate or hyaluronic acid (Table 1) .
Unlabeled SMC were identified in autoradiograms and were found in the intima and the media at 7 days. The possibility that these cells were leukocytes and not SMC was eliminated by demonstrating that they did not stain with anti-rat leukocyte antibody (Accurate Chemicals, Inc.) in histological sections or in single cell preparations; furthermore, by transmission electron microscopy, no leukocytes could be found in the intima and all cells inhibited SMC morphology (data not shown).
The growth fractions for the periods 0-3 days and 0-7 days were calculated as previously described. The fraction of unlabeled cells at any time point (Fig. 2) is multiplied by the DNA content of that vessel; this gives the amount of DNA (or SMC) that has not undergone proliferation during the time interval. The growth fraction is, then, this number divided by the DNA content of vessels removed immediately after injury, subtracted from one, and multiplied by 100.
In vessels of control animals given lactated Ringer's solution intravenously, the calculated growth fractions were similar to those reported previously ( Fig. 3) and were not significantly different at 3 and 7 days. Carotids from heparin-treated rats showed a marked reduction in the growth fraction at both 3 and 7 days; however, the shape of the curve for heparin-treated and control animals was similar.
The fraction of unlabeled SMC in the media migrating into the intima between 1 and 7 days was computed and found to be significantly less in the Figures 1 and 2 for the time intervals 0 to 3 days and 0 to 7 days for control and heparm-treated rats The differences between heparm-treated and control rats are significant at 7 days (P<0 05, t-test) heparin-treated rats (Table 2) , although the total mass of unlabeled SMC (unlabeled index X DNA; heparin-treated: 1.13 ± 0.13 ng DNA/5 mm, controls: 0.86 ± 0.07 ng DNA/5 mm) in the injured arterial wall (intima plus media) was greater than in controls. These data demonstrated that heparin could block entry of SMC into the growth fraction and migration of unlabeled SMC from the media to the intima. Previous experiments have demonstrated that the heparin must be given within the first 24 hours after injury to have a maximal effect . Whether these effects would be reversed if the heparin were withdrawn, or whether an early and brief period of heparin administration could have a long-lasting impact on SMC growth fraction, migration, and total cell accumulation, has not been evident. To address these questions, two experiments were performed. In the first, heparin was stopped at 3 days after injury in one group of rats (group 1) and started in another group (group 2) only at 3 days, calculations made using measurements of DNA content and thymidine labeling demonstrated that growth fraction and unlabeled SMC migration were inhibited in group 1 but not in group 2, compared to control (Table 3 ). In the second experiment, heparin was administered for 7 days Circulation Research/Vol. 58, No, 6, June 1986 Results are expressed as mean ± SEM (n = 4 for each group) * Animals in group 1 received heparin (0.3 mg/kg per hr) intravenously by minipump from the time of surgery to day 3 after surgery, while animals in group 2 received lactated Ringer's solution (LR) On day 3, the minipumps were switched between groups f Significantly different from group 2 (P < 0 05, one-tail /-test). + Significantly different from control (Fig 3; Table 1) (P < 0 05, one-tail /-test) after surgery and DNA was measured at 14 or 28 days. At both times, SMC accumulation in heparintreated animals was markedly reduced (Table 4 ).
Effect of Heparin and Other Glycosaminoglycans on SMC Proliferation at 14 Days
Discussion
In this study, we have demonstrated that the inhibition of intimal thickening in injured artery by heparin is the consequence of both inhibition of SMC entry into the growth fraction and migration of SMC from the media into the intima. These effects are long lasting, and are not reversed even if the heparin is stopped after a short course (7 days) of administration.
Heparin Effect: Decreased Growth Fraction
Our earlier experiments with the ballooned rat carotid demonstrated that heparin treatment reduced intimal thickening, total cell number, and thymidine labeling at various intervals after injury . In addition, we found that in a 2-week growth assay, the heparin was equally effective if started before or just after injury, but was considerably less effective if started 48 or 96 hours after injury. These observations suggested that heparin had a direct effect on SMC proliferation, and that the effect was most pronounced if the heparin was present before SMC actually started 
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Results are expressed as mean ± SEM (n = 5 for each group). * Animals received either hepann (0.3 mg/kg per hr) or lactated Ringer's solution (LR) intravenously by means of a 7-day minipump inserted at the time of ballooning, and were then killed at either 14 or 28 days after carotid injury f Significantly different from control (P < 0 05, one-tail (-test) proliferating. There were several possible explanations for these findings: (1) Heparin could be delaying early entry of cells into the growth fraction to a later time (prolongation of Gi). At late times, the growth fraction would then be expected to be the same as control.
(2) Heparin could inhibit a subset of stimulated cells in d so that a smaller growth fraction would be measured both early and late.
(3) Heparin could be toxic for SMC and kill primarily proliferating SMC; this would have the net effect of reducing the growth fraction over time.
In an earlier study, we developed a method for measuring growth fraction of SMC in vivo based on the assumptions that some fraction of the initial population of cells in the wall would never proliferate and that all proliferating cells could be labeled by tracer quantities of [ 3 H]thymidine delivered continuously . We demonstrated that the amounts of [ 3 H]thymidine used produced no detectable effect upon SMC growth in 7-and 14-day assays. The growth fraction was calculated after first quantifying the nondividing DNA content at a particular time after carotid injury (unlabeled fraction obtained from autoradiography multiplied by DNA content). The growth fraction for that period of time was then equal to one, minus the ratio of the nondividing DNA content to the initial DNA content.
We have now applied this technique to the measurement of SMC growth fraction in the injured carotids of heparin-treated rats. Three significant points emerge: (1) over a 3-or a 7-day interval, heparin treatment causes a decrease in SMC growth fraction; (2) the growth fraction in both control and heparin-treated rats is relatively constant between day 3 and day 7, even if the heparin is stopped at day 3; (3) injured arteries removed at late times from animals treated briefly with heparin exhibit a marked reduction in SMC growth fraction and total SMC accumulation, compared to an appropriate control. These results confirm our earlier observations in untreated animals that SMC commit themselves to enter the growth cycle early (within 3 days of injury) and do not start proliferating at later times. Furthermore, these findings, taken together with earlier ones, provide clear evidence that heparin is blocking SMC in Gi and preventing entry into the growth cycle. This conclusion is supported by in vitro cell cycle data obtained by flow microfluorimetry demonstrating that proliferating bovine SMC are arrested by heparin in G 0 -Gi (Castellot et al., 1985a) . We have recently investigated the early period (first 48 hours) after arterial injury and have demonstrated that ornithine decarboxylase activity exhibits a sharp peak at 6 hours after injury, and that SMC enter S phase between 24 and 27 hours (Majesky et al., 1985) . Heparin administration does not affect the induction of ornithine decarboxylase activity, but does prevent entry into S phase; these results thus support the conclusion that the heparin block is in late Gi. In the injured carotid this block is not reversed if the heparin is stopped on day 3. This suggests that, at least in injured arteries, commitment to entry into the growth cycle is an early and discrete event. Heparin treatment permanently prevents a subgroup of SMC from leaving Go-Gi. Other forms of stimulus such as recurrent or chronic endothelial injury might be associated with a different pattern of SMC response and might require a more protracted course of heparin treatment for suppression of SMC proliferation.
Why only a fraction of the SMC stimulated by injury are inhibited by heparin is uncertain. In doseresponse experiments, we have been able to achieve about 70% inhibition at a maximum, regardless of the source of heparin (Clowes et al., 1983c) . Hoover et al. (1980 ), Castellot et al. (1982 , and Fritze et al. (1985) have all reported a similar experience with in vitro systems. It is possible that there are different subtypes of SMC, some of which lack specific receptors for heparin.
The precise biochemical mechanism of heparin inhibition of SMC proliferation is not known. A number of possibilities have been proposed, including binding to the cell surface (Castellot et al., 1985b) with inhibition of pyrimidine transport (Castellot et al., 1985a) , inhibition of growth factor binding (Paul et al., 1980) , or inhibition of the formation of cell attachments (Schubert and LaCorbiere, 1980) . Preliminary observations demonstrating a lack of effect of hepann upon platelet-derived growth factor and epidermal growth factor binding (unpublished data and personal communication from C. Reilly and R. Rosenberg) suggest that heparin does not act by inhibiting growth factor binding. Furthermore, Hoover et al (1980) have shown that serum passed over a heparin-sepharose column is not depleted of growth-promoting activity. Bornstein (1984, 1985) and Cochran et al. (1985) have shown that heparin induces SMC to synthesize several new proteins; have also demonstrated that heparin causes the release of thrombospondin, an attachment protein, from the matrix into the media. This finding raises the possibility that heparin affects SMC proliferation and migration via an extracellular mechanism, and without being bound and internalized.
Heparin Effect: Decreased SMC Migration
In rat carotid arteries, SMC reside only in the media. Hence, a critical step in the development of intimal and wall thickening is the migration of SMC from the media into the intima. SMC begin to migrate approximately 4 days after carotid injury (Clowes et al., 1983a) We recently have provided evidence that not only proliferating but also nondividing SMC can migrate ; approximately 50% of the migrating cells may in fact be nondividing! Majack and Clowes (1984) and, more recently, Orlidge and D'Amore (1984) have shown that SMC and pencyte migration in vitro is inhibited by heparin and related glycosaminoglycans. The effect is specific for SMC, since endothelium and fibroblast migration is not inhibited.
The observations reported here confirm the in vitro data, and indicate that in the presence of heparin, fewer nondividing SMC migrate into the intima by 7 days; in a previous study, we demonstrated that endothelial migration and proliferation are unaffected by heparin treatment . Since migration can occur in the absence of proliferation and still can be inhibited by heparin, it is possible that the heparin effects on SMC migration and proliferation may be independent of one another The experiment in which groups of animals were given heparin either during the first 3 days or from day 4 to day 7 was designed to test this hypothesis. Most of the cells destined to proliferate enter the growth cycle between day 1 and 2, whereas cell migration from the media to the intima does not start until day 4. However, the data from this experiment demonstrated that significant inhibition of SMC migration was obtained only if heparin was given in the early period after carotid injury, before migration had actually started. These Circulation Research/Vol. 58, No. 6, June 1986 results tend to refute the hypothesis, and to support the possibility that the effects of heparin on proliferation and migration are linked. The biochemical basis for either one remains to be established.
In summary, we have shown that two important effects of heparin upon the reparative process in injured artery are to limit SMC entry into the growth fraction and to inhibit migration of SMC into the intima. In normal vessels and vessels potentially at risk for atherosclerosis, heparin-related molecules synthesized either by overlying endothelium or by neighboring quiescent SMC, if present in sufficient amounts, might perform similar functions to suppress the growth of vascular plaques.
